Abstract
The use of positron-emitting radionuclides, especially 18 F labeled fluorodeoxy glucose (18 F-FDG), has increased recently due to its role in oncology. This has paved the way to look for other uses for these agents. The use of positron emission tomography (PET) as a noninvasive tool for imaging the heart in coronary artery disease to look for perfusion defects and viability has already been established. This has helped us to know the extent of myocardial blood flow, the metabolic changes occurring in the myocardium, and changes in the cardiac autonomic innervations in various pathological conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
For Further Reading
Bateman TM, Heller GV, McGhie AI, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99 m sestamibi SPECT. J Nucl Cardiol. 2006;13:24–33. PubMed: 16464714.
Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation. 2007;115:1464–80.
Lortie M, Beanlands RS, Yoshinaga K, Klein R, Dasilva JN, de Kemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging. 2007;34:1765–74.
Machac J. Cardiac positron emission tomography imaging. Semin Nucl Med. 2005;35:17–36.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer India
About this chapter
Cite this chapter
Pradhan, P.K., Sankar, G. (2015). Role of PET in Coronary Artery Disease. In: Das, B. (eds) Positron Emission Tomography. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2098-5_10
Download citation
DOI: https://doi.org/10.1007/978-81-322-2098-5_10
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2097-8
Online ISBN: 978-81-322-2098-5
eBook Packages: MedicineMedicine (R0)